Search Results 271-280 of 20670 for autoimmune hepatitis
Seeking to shorten wait time to transplant for patients with end-stage liver disease, Mayo Clinic transplant hepatologists and surgeons led a multisite, ...
About this study. The purpose of this study is to. evaluate the potential of PAPP-A as a therapeutic target in ADPKD, we collaborated with Calico and ...
Learn about available training opportunities in the Genetics of Liver Disease Lab led by Kirk J. Wangensteen, M.D., Ph.D., at Mayo Clinic's campus in ...
The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for ...
Conditions include but are not limited to acute liver failure, biliary atresia, metabolic liver disease, viral hepatitis, urea cycle defects, liver cancers, ...
... autoimmune diseases. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
The purpose of this study is to assess the combined impact of post-processing methods that quantify potential biomarkers of chronic liver disease (AEF, fECS) ...
... liver disease. Current efforts include studies of the incidence and causes of liver disease, the development of novel diagnostic tools, and clinical trials ...
... liver disease, hepatitis and other liver diseases. He is board-certified in internal medicine, gastroenterology, and transplant hepatology. Dr. Mousa is an ...
See faculty and staff of Dr. Hirsova's Liver Disease Immunobiology Lab at Mayo Clinic's campus in Minnesota.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.